July 23, 2018, The Mount Sinai Hospital A new Mount Sinai study, published July 23 in the journal Nature Neuroscience, provides important insight into how microglia, cells that form a branch of the immune system inside the brain, go about their job of clearing out dying and non-functional neurons—and how they sometimes mistakenly attack healthy neurons, an...
Tag: <span>Alzheimers</span>
Post
New research focuses on treating non-cognitive symptoms of people with dementia
July 24, 2018, Alzheimer’s Association New research presented at the Alzheimer’s Association International Conference (AAIC) 2018 in Chicago focuses on the recent successes and ongoing challenges of drug and non-drug treatments for the non-cognitive symptoms experienced by people living with Alzheimer’s dementia. Diagram of the brain of a person with Alzheimer’s Disease. Credit: Wikipedia/public domain....
Post
First practice guidelines for clinical evaluation of Alzheimer’s disease
July 22, 2018, Alzheimer’s Association Despite more than two decades of advances in diagnostic criteria and technology, symptoms of Alzheimer’s disease and Related Dementias (ADRD) too often go unrecognized or are misattributed, causing delays in appropriate diagnoses and care that are both harmful and costly. Contributing to the variability and inefficiency is the lack of...
Post
Heart failure: The Alzheimer’s disease of the heart?
Protein clumping may contribute to heart failure development and could be used as a diagnostic tool for testing therapies or disease progression Date: May 9, 2018 Source: Johns Hopkins Medicine Summary: Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, protein clumps appear to accumulate...
Post
Can nanotechnology help treat Alzheimer’s?
June 19, 2018 by Ileana Varela, Florida International University Alzheimer’s disease (AD) is the most common form of dementia. It takes a devastating toll on patients and family members, who are usually the caregivers. Current drugs only treat symptoms of AD, not its causes. June is Alzheimer’s and Brain Awareness Month. FIU researchers are studying a new approach...
Post
Alzheimer’s breakthrough: Brain metals that may drive disease progression revealed
In brains affected by Alzheimer’s, researchers identify chemically reduced iron species, with mineral forms including a magnetic iron oxide UNIVERSITY OF WARWICK Breakthrough in description of metals in brain which may drive the progression of Alzheimer’s disease, made by international research collaboration, including University of Warwick In brains affected by Alzheimer’s, researchers identify chemically reduced iron species, with mineral forms...
Post
New study suggests viral connection to Alzheimer’s disease
ARIZONA STATE UNIVERSITY Of the major illnesses facing humanity, Alzheimer’s disease (AD) remains among the most pitiless and confounding. Over a century after its discovery, no effective prevention or treatment exists for this progressive deterioration of brain tissue, memory and identity. With more people living to older ages, there is a growing need to clarify...
Post
Lighting intervention improves sleep and mood for Alzheimer’s patients
A tailored lighting intervention in nursing homes can positively impact sleep, mood and behavior for patients with Alzheimer’s disease, according to preliminary findings from a new study. People with Alzheimer’s disease and related dementias may experience sleep problems, wandering, and associated daytime irritability. This study tested whether a tailored daytime lighting intervention could improve sleep and behavior in Alzheimer’s patients living in...
Post
Imec Develops Wireless Eye-Tracking Glasses to Aid in Research of Neurological Disorders
Many neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, can often present with symptoms of abnormal eye movements. Much research has been done in utilizing eye movement tracking technology to help with the diagnosis of these diseases and the monitoring of their progression. Traditional eye-tracking technology relies heavily on cameras, which, while accurate, are typically large...
Post
New molecule may stop Alzheimer’s from spreading
A compound called cambinol shows great promise as a future Alzheimer’s drug. The molecule has halted the spread of the toxic brain protein tau in cell cultures and mice. A brain protein called tau is known to play a key role in the development of Alzheimer’s disease. Our brain cells have a “transport system” made of...